Literature DB >> 24459492

A case of primary aldosteronism with end stage renal disease.

Hyun Hee Na1, Kyung Jun Park1, Sun Young Kim1, Haeng Il Koh1.   

Abstract

A 52-year-old woman was referred to our hospital due to chronic renal failure with a 10-year history of hypertension. We found polycystic kidney disease, pulmonary tuberculosis and an aldosterone-producing adrenocortical mass. At this time, her serum potassium level and blood pressure were within the normal range. She refused hemodialysis and then was hospitalized because of uremic encephalopathy. On admission, her serum potassium level was normal without treatment and plasma aldosterone concentration highly elevated. She received hemodialysis, and thereafter hypokalemia developed. We then administered spironolactone, whereupon serum potassium level returned to the normal range. In this case, we thought that normokalemia was balanced hypokalemia of primary aldosteronism with hyperkalemia of chronic renal failure, and that hypokalemia developed after hemodialysis was due to an imbalanced primary aldosteronism with end stage renal disease.

Entities:  

Keywords:  End stage renal disease; Hemodialysis; Primary aldosteronism

Year:  2006        PMID: 24459492      PMCID: PMC3894531          DOI: 10.5049/EBP.2006.4.2.83

Source DB:  PubMed          Journal:  Electrolyte Blood Press        ISSN: 1738-5997


  9 in total

1.  Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-01

2.  Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.

Authors:  W Oelkers; S Diederich; V Bähr
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Renin and juxtaglomerular apparatus in a patient with primary aldosteronism complicated by chronic renal failure.

Authors:  S Iyori; T Saruta; K Kondo; Y Ozawa; J Hata
Journal:  South Med J       Date:  1976-07       Impact factor: 0.954

4.  The changing clinical spectrum of primary aldosteronism.

Authors:  E L Bravo; R C Tarazi; H P Dustan; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

5.  Primary aldosteronism associated with chronic renal failure. Report of a case.

Authors:  T Nakada; M Kimura
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

6.  Aldosterone-producing adenoma without hypertension: a report of two cases.

Authors:  M C Vantyghem; N Ronci; F Provost; A Ghulam; J Lefebvre; X Jeunemaitre; A Tabarin
Journal:  Eur J Endocrinol       Date:  1999-09       Impact factor: 6.664

Review 7.  A case of normoreninemic aldosterone-producing adenoma associated with chronic renal failure: case report and literature review.

Authors:  Hiroyuki Koshiyama; Takeshi Fujisawa; Naomitsu Kuwamura; Yoshio Nakamura; Hiroshi Kanamori; Emi Oida; Akira Hara; Takashi Suzuki; Hironobu Sasano
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

8.  A case of primary aldosteronism with chronic renal failure undergoing hemodialysis treatment.

Authors:  K Matsuda; K Shimamoto; N Ura; H Ogata; Y Shizukuda; M Iwakura; A Nozawa; K Kikuchi; O Iimura
Journal:  Endocrinol Jpn       Date:  1989-10

9.  Atrial natriuretic peptide during mineralocorticoid escape in the human.

Authors:  R S Zimmerman; B S Edwards; T R Schwab; D M Heublein; J C Burnett
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

  9 in total
  1 in total

1.  A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease.

Authors:  Sasan Mirfakhraee; Maria Rodriguez; Niloofar Ganji; Richard J Auchus; Oksana Hamidi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.